Phenotypic and genotypic drug susceptibility patterns of Mycobacterium tuberculosis isolates from pulmonary tuberculosis patients in Central and Southern Ethiopia

• Published in: PloS one 2023-09, Vol.18 (9), p.e0285063-e0285063
• Main Authors: Tilahun, Melaku, Wegayehu, Teklu, Wondale, Biniam, Gebresilase, Tewdros Tariku, Gebreyohannes, Tesfaye, Tekola, Abraham, Alemu, Mekdes, Neway, Sebsib, Adnew, Bethlehem, Nassir, Maeruf Fetu, Kassahun, Yonas, Aseffa, Abraham, Bobosha, Kidist
• Format: Article
• Language: English
• Subjects: Analysis; Biology and Life Sciences; Coronaviruses; Cross-Sectional Studies; Diagnosis; Discordance; Drug resistance; Drug therapy; Ethiopia - epidemiology; Gene deletion; Gene mutations; Gene sequencing; Genes; Genomes; Genotype; Genotype & phenotype; Genotypes; Glycerin; Glycerol; Health aspects; Hospitals; Humans; Infectious diseases; Isoniazid; KatG gene; Laboratories; Latent Tuberculosis; Medical diagnosis; Medicine and Health Sciences; Microbial Sensitivity Tests; Microscopy; Missing data; Mutation; Mycobacterium tuberculosis; Mycobacterium tuberculosis - genetics; People and Places; Phenotype; Polymerase chain reaction; Public health; Pyruvic acid; Regions; Rifampin; RNA polymerase; RpoB protein; Sputum; Tuberculosis; Tuberculosis, Pulmonary - diagnosis; Tuberculosis, Pulmonary - drug therapy; Tuberculosis, Pulmonary - epidemiology; Whole genome sequencing
• ISSN: 1932-6203; 1932-6203
• DOI: 10.1371/journal.pone.0285063

The persistence of tuberculosis (TB) infection in some patients after treatment has highlighted the importance of drug susceptibility testing (DST). This study aimed to determine the drug susceptibility patterns of Mycobacterium tuberculosis (M. tuberculosis) isolates from pulmonary TB (PTB) patients in Central and Southern Ethiopia. A health institution-based cross-sectional study was conducted between July 2021 and April 2022. Sputum samples were collected from newly diagnosed smear microscopy and/or Xpert MTB/RIF-positive PTB patients. The samples were processed and cultivated in Lowenstein-Jensen (LJ) pyruvate and glycerol medium. M. tuberculosis isolates were identified using polymerase chain reaction (PCR) based region of difference 9 (RD9) deletion typing. Phenotypic DST patterns of the isolates were characterized using the BACTEC MGIT™ 960 instrument with SIRE kit. Isoniazid (INH) and Rifampicin (RIF) resistant M. tuberculosis isolates were identified using the GenoType® MTBDRplus assay. Sputum samples were collected from 350 PTB patients, 315 (90%) of which were culture-positive, and phenotypic and genotypic DST were determined for 266 and 261 isolates, respectively. Due to invalid results and missing data, 6% (16/266) of the isolates were excluded, while 94% (250/266) were included in the paired analysis. According to the findings, 14.4% (36/250) of the isolates tested positive for resistance to at least one anti-TB drug. Gene mutations were observed only in the rpoB and katG gene loci, indicating RIF and high-level INH resistance. The GenoType® MTBDRplus assay has a sensitivity of 42% and a specificity of 100% in detecting INH-resistant M. tuberculosis isolates, with a kappa value of 0.56 (95%CI: 0.36-0.76) compared to the BACTEC MGIT™ DST. The overall discordance between the two methods was 5.6% (14/250) for INH alone and 0% for RIF resistance and MDR-TB (resistance to both INH and RIF) detection. This study reveals a higher prevalence of phenotypic and genotypic discordant INH-resistant M. tuberculosis isolates in the study area. The use of whole-genome sequencing (WGS) is essential for gaining a comprehensive understanding of these discrepancies within INH-resistant M. tuberculosis strains.